Engineered Microbial Sensors for Aromatic Compound Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biosensors lack high ligand specificity for structurally similar aromatic compounds like phenylalanine, tyrosine, phenylethylamine, and tyramine, which are associated with distinct medical conditions, limiting their ability to differentiate between these metabolites and accurately diagnose disorders.
Innovation Solution
Engineered microorganisms, such as E. coli, are equipped with selectively tuned TrpR, TyrR, and TynA-FeaR sensor systems, where specific amino acids in the ligand-binding sites are mutated to enhance selectivity and sensitivity, allowing for precise detection of these aromatic compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current biosensors are used to detect aromatic compounds, then detection capability is provided, but ligand specificity for structurally similar compounds is insufficient
Solution Approach 1:
The patent applies local quality by introducing specific amino acid mutations at precise positions within the ligand-binding site of regulator proteins (TyrR, TrpR, TynA, FeaR). These localized changes at specific residues (e.g., positions 10, 14, 76, 81, 103, 108, 109, 110, 414, 415, 494, 504, 506) alter the binding pocket's chemical properties to recognize specific aromatic compounds while maintaining overall protein structure and function.
Solution Approach 2:
The patent employs parameter changes by systematically varying amino acid residues in the ligand-binding site through mutagenesis. This changes the physical and chemical parameters of the binding pocket (such as hydrophobicity, charge, steric constraints) to optimize recognition of specific aromatic compounds like phenylalanine, tyrosine, phenylethylamine, or tyramine, thereby improving measurement precision and differentiation capability.
2Measurement precision
If amino acid mutations are introduced in ligand-binding sites to enhance selectivity, then ligand specificity is improved, but protein structure stability may be compromised
Solution Approach 1:
The mutations are confined to specific positions within the ligand-binding site rather than throughout the entire protein structure. This localized approach allows selective optimization of ligand recognition while preserving the overall structural framework and stability of the regulator protein.
Solution Approach 2:
The patent carefully selects amino acid substitutions that modify local binding properties without introducing destabilizing changes. The mutations are chosen to optimize ligand specificity while maintaining the structural integrity and functional stability of the protein, balancing selectivity enhancement with structural preservation.
3Adaptability or versatility
If multiple sensor systems are engineered to detect different aromatic compounds, then detection versatility is improved, but device complexity increases
Solution Approach 1:
The patent develops a universal platform using four different regulator protein families (TyrR, TrpR, TynA, FeaR) that can each be engineered to detect various aromatic compounds. This multi-functional approach allows a single sensor system design framework to be applied across multiple detection targets, reducing overall system complexity while maintaining versatility.
Solution Approach 2:
The patent divides the detection task into separate specialized sensor modules, each based on a specific regulator protein optimized for particular aromatic compounds. This segmentation allows independent optimization of each sensor while maintaining a modular architecture that simplifies system integration and management.
Data Source
AI summary
Among the various aspects of the present disclosure is the provision of molecular sensors, microbial sensors, constructs, systems, and methods for selectively detecting aromatic compounds.